Lack of deleterious somatic mutations in the CD95 gene of plasmablasts from systematic lupus erythematosus patients and autoantibody-producing cell lines

European Journal of Immunology

Volumn 32, Issue 12, 2002, Pages 3785-3792

  Kurth, Julia ^a   Perniok, Andreas ^a   Schmitz, Roland ^a   Iking Konert, Christof ^b   Chiorazzi, Nicholas ^e   Thompson, Keith M ^c   Winkler, Thomas ^d   Rajewsky, Klaus ^a   Küppers, Ralf ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^e Nikolaus Fiebiger Zentrum Mol Med ^*

Author keywords

CD95; Plasmablast; Rheumatoid arthritis; Somatic mutation; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY; AZITHROMYCIN; CLARITHROMYCIN; FAS ANTIGEN; GENTAMICIN; LIGAND; PREDNISOLONE;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL CLONE; CELL LINE; CELL SELECTION; CONTROLLED STUDY; GENE AMPLIFICATION; GENE REARRANGEMENT; GERMINAL CENTER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEQUENCE ANALYSIS; SOMATIC MUTATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0036919202     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200212)32:12<3785::AID-IMMU3785>3.0.CO;2-E     Document Type: Article

References (31)

1. Krammer, P. H., CD95's deadly mission in the immune system. Nature 2000. 407: 789-795.
2. Nagata, S., Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inclucing Fas receptor: a lesson from the mouse model. J. Hum. Genet. 1998. 43: 2-8.
3. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J. and Puck, J. M., Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995.81:935-946.
4. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A., Debatin, K. M., Fischer, A. and de Villartay, J. P., Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995. 268: 1347-1349.
5. Gronbaek, K., Straten, P. T., Ralfkiaer, E., Ahrenkiel, V., Andersen, M. K., Hansen, N. E., Zeuthen, J., Hou-Jensen, K. and Guldberg, P., Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood 1998. 92: 3018-3024.
6. Müschen, M., Rajewsky, K., Krönke, M. and Küppers, R., The origin of CD95 gene mutations in B cell lymphoma. Trends Immunol. 2002. 23: 75-80.
7. Takakuwa, T., Dong, Z., Takayama, H., Matsuzuka, F., Nagata, S. and Aozasa, K., Frequent mutations of Fas gene in thyroid lymphoma. Cancer Res. 2001. 61: 1382-1385.
8. + T cells. Nature 1995. 376:181-184.
9. Hoch, S., Boyd, M., Malone, B., Gonye, G. and Schwaber, J., Fas-mediated apoptosis eliminates B cells that acquire self-reactivity during the germinal center response to NR Cell. Immunol. 2000. 203: 103-110.
10. Müschen, M., Re, D., Jungnickel, B., Diehl, V., Rajewsky, K. and Küppers, R., Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J. Exp. Med. 2000 192:1833-1840.
11. van Eijk, M., Defrance, T., Hennino, A. and Groot, C., Death-receptor contribution to the germinal-center reactions. Trends Immunol. 2001. 22:677-682.
12. Odendahl, M., Jacobi, A., Hansen, A., Feist, E., Hiepe, F., Burmester, G. R., Lipsky, P. E., Radbruch, A. and Dörner, T., Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J. Immunol. 2000. 165: 5970-5979.
13. Spronk, P. E., Horst, G., Van Der Gun, B. T., Limburg, P. C. and Kallenberg, C. G., Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 1996.104:446-453.
14. Arce, E., Jackson, D. G., Gill, M. A., Bennett, L. B., Banchereau, J. and Pascual, V., Increased frequency of pregerminal center B cells and plasma cell presursors in the blood of children with systemic lupus erythematosus. J. Immunol. 2001. 167: 2361-2369.
15. Shibata, S., Sasaki, T., Hatakeyama, A., Munakata, Y., Hirabayashi, Y. and Yoshinaga, K., Clonal frequency analysis of B cell producing pathogenic anti-DNA anti body-associated idiotypes in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 1992. 63: 252-258.
16. Schwab, J., Lukowsky, A., Volk, H. D., Peter, H. H. and Melchers, I., Precursor frequencies for DNA-specific B lymphocytes in patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 1994. 96:450-457.
17. Dar, O., Salaman, M. R., Seifert, M. H. and Isenberg, D. A., Spontaneous antibody-secreting cells against DNA and common environmental antigens in systemic lupus erythematosus. J. Autoimmun. 1990. 3: 523-530.
18. Mach, P. S., Kharouby, M., Lutcher, F., Olivier, J. L., Bazely, N., Dougados, M. and Amor, B., The in vitro production and regulation of anti-double stranded DNA antibodies by peripheral blood mononuclear cells from normals and patients with systemic lupus erythematosus. Clin. Exp. Immunol. 1984. 57: 338-344.
19. Bobrove, A. M. and Miller, P., Depressed in vitro B-lymphocyte differentiation in systemic lupus erythematosus. Arthritis Rheum. 1977.20:1326-1333.
20. Winkler, T. H., Jahn, S. and Kalden, J. R., IgG human monoclonal anti-DNA autoantibodles from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 1991. 85: 379-385.
21. Chiorazzi, N. and Reeves, W. H., Description and partial characterization of a nucleolar RNA-associated autoantigen defined by a human monoclonal antibody. J. Exp. Med. 1987. 164: 1172-1187.
22. Kaplan, S., Hyman, K., Brooks, R., Wakai, M., Hashimoto, S., Furie, R. and Chiorazzi, N., Monoclonal IgM, IgG, and IgA human rheumatoid factors produced by synovial tissue-derived, EBV-transformed B cell lines. Clin. Immunol. Immunopathol. 1993.66:18-25.
23. Cascino, I., Papoff, G., De Maria, R., Testi, R. and Ruberti, G., Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J. Immunol. 1996. 156: 13-17.
24. Plumas, J., Jacob, M. C., Chaperot, L., Molens, J. P., Sotto, J. J. and Bensa, J. C., Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis. Blood 1998. 91: 28752885.
25. Herrmann, M., Voll, R. E., Kolowos, W., Lorenz, H.-M. and Kalden, J. R., Etiopathogenesis of systemic lupus erythematosus. The Immunologist 2000: 8: 66-71.
26. Jefferis, R., Rheumatoid factors, B cells and immunoglobulin genes. Br. Med. Bull. 1995. 51: 312-331.
27. Mageed, R. A., Borretzen, M., Moyes, S. P., Thompson, K. M. and Natvig, J. B., Rheumatoid factor autoantibodies in health and disease. Ann. NY Acad. Sci. 1997. 815: 296-311.
28. Thompson, K. M., Randen, I., Borretzen, M., Forre, O. and Natvig, J. B., Variable region gene usage of human monoclonal rheumatoid factors derived from healthy donors following immunization. Eur. J. Immunol. 1994. 24: 1771-1778.
29. Kanzler, H., Küppers, R., Helmes, S., Wacker, H. H., Chott, A., Hansmann, M. L. and Rajewsky, K., Hodgkin and Reed-Sternberg-like cells in B cell chronic lymphocytic leukemia represent the outgrowth of single germinal-center B-cell-derived clones: potential precursors of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. Blood 2000. 95:1023-1031.
30. Goossens, T., Klein, U. and Küppers, R., Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc. Natl.. Acad. Sci. USA 1998. 95:2463-2468.
31. Küppers, R., Sonoki, T., Satterwhite, E., Gesk, S., Harder, L., Oscier, D. G., Tucker, R W., Dyer, M. J. and Siebert, R., Lack of somatic hypermutation of IG V(H) genes in lymphoid malignancies with t(2;14)(pl3;q32) translocation involving the BCL11A gene. Leukemia 2002. 16: 937-939.